BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.51 CNY | +0.98% |
|
+4.49% | -9.59% |
| 02/04 | Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023. | CI |
| 29/02 | Bloomage Biotech Names CFO | MT |
Evolution of the average Target Price on Bloomage BioTechnology Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
a58482880d9bfb80be1bced9330822._ZKJ1-8_bGR6CPrW8rNRC_lpXTJmiI9wJn6sH4X7EGY.pPnnh71MXwE7OqWjmNQBU7IrCHhU_b8jeUfpbbyMfwzJ5-inlUYVITZxiQ~e705bf0e050913ac6e81dba0b10d9c21
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
60.51
CNY
Average target price
83.72
CNY
Spread / Average Target
+38.35%
High Price Target
131
CNY
Spread / Highest target
+116.49%
Low Price Target
45
CNY
Spread / Lowest Target
-25.63%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- 688363 Stock
- Consensus Bloomage BioTechnology Corporation Limited
